The diabetic foot.
暂无分享,去创建一个
[1] A. Boulton,et al. The global burden of diabetic foot disease , 2005, The Lancet.
[2] A. Jirkovska,et al. Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy , 2006, Diabetes Care.
[3] A. Manto,et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. , 2005, Diabetes care.
[4] Kirk E. Smith,et al. Structural Changes in the Forefoot of Individuals with Diabetes and a Prior Plantar Ulcer , 2002, The Journal of bone and joint surgery. American volume.
[5] Benjamin A Lipsky,et al. The value of a wound score for diabetic foot infections in predicting treatment outcome: A prospective analysis from the SIDESTEP trial , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[6] B. De,et al. Complications of Diabetes Mellitus , 2016 .
[7] W. Marston,et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. , 2006, Journal of vascular surgery.
[8] J. R. Mekkes,et al. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation , 1999, Archives of Dermatological Research.
[9] A. M. Foster,et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial , 2001, Diabetologia.
[10] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[11] D. Armstrong,et al. Preventing foot ulcers in patients with diabetes. , 2005, JAMA.
[12] F. Logerfo,et al. Lower extremity revascularization in diabetes: late observations. , 2000, Archives of surgery.
[13] A. Malik,et al. Study of plasmid-mediated extended-spectrum β-lactamase-producing strains of enterobacteriaceae, isolated from diabetic foot infections in a North Indian tertiary-care hospital. , 2012, Diabetes technology & therapeutics.
[14] K. Brismar,et al. Skin Capillary Circulation is More Impaired in the Toes of Diabetic Than Non‐diabetic Patients with Peripheral Vascular Disease , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[15] D G Smith,et al. The Independent Contributions of Diabetic Neuropathy and Yasculopatny in Foot Ulceration: How great are the risks? , 1995, Diabetes Care.
[16] C. Cetrulo,et al. Endostatin Inhibits Ischemia-Induced Neovascularization and Increases Ischemic Tissue Loss , 2004, Annals of plastic surgery.
[17] J. Varani,et al. All-trans-retinoic acid suppresses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture. , 2004, The American journal of pathology.
[18] J. Chung,et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. , 2000, The Journal of investigative dermatology.
[19] N. Schaper,et al. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies , 2004, Diabetes/Metabolism Research Reviews.
[20] A C Shore,et al. Skin Capillary Density in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[21] C. Sumner,et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance , 2003, Neurology.
[22] P. Mandal,et al. A comparative study between total contact casting and conventional dressings in the non-surgical management of diabetic plantar foot ulcers. , 2008, Journal of the Indian Medical Association.
[23] A. Malik,et al. A study of biofilm production by gram-negative organisms isolated from diabetic foot ulcer patients , 2011 .
[24] I. Baumgartner,et al. Balloon Angioplasty in Chronic Critical Limb Ischemia: Factors Affecting Clinical and Angiographic Outcome , 2002, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[25] P. Sönksen,et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.
[26] P. Stewart,et al. Biofilms in chronic wounds , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[27] R J Hinchliffe,et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment , 2008, Diabetes/metabolism research and reviews.
[28] T. H. Lee,et al. Charcot foot: the diagnostic dilemma. , 2001, American family physician.
[29] T. Dinh,et al. Microvascular Changes in the Diabetic Foot , 2006, The international journal of lower extremity wounds.
[30] Jamal Ahmad,et al. Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. , 2011, Foot.